Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
- PMID: 38617549
- PMCID: PMC11008265
- DOI: 10.7150/ijbs.92274
Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Abstract
Cholesterol is crucial for cell survival and growth, and dysregulation of cholesterol homeostasis has been linked to the development of cancer. The tumor microenvironment (TME) facilitates tumor cell survival and growth, and crosstalk between cholesterol metabolism and the TME contributes to tumorigenesis and tumor progression. Targeting cholesterol metabolism has demonstrated significant antitumor effects in preclinical and clinical studies. In this review, we discuss the regulatory mechanisms of cholesterol homeostasis and the impact of its dysregulation on the hallmarks of cancer. We also describe how cholesterol metabolism reprograms the TME across seven specialized microenvironments. Furthermore, we discuss the potential of targeting cholesterol metabolism as a therapeutic strategy for tumors. This approach not only exerts antitumor effects in monotherapy and combination therapy but also mitigates the adverse effects associated with conventional tumor therapy. Finally, we outline the unresolved questions and suggest potential avenues for future investigations on cholesterol metabolism in relation to cancer.
Keywords: antitumor immunity; cholesterol homeostasis; drug repurposing; metastasis; statin; tumor microenvironment.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.Front Endocrinol (Lausanne). 2022 Aug 15;13:988295. doi: 10.3389/fendo.2022.988295. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36046791 Free PMC article. Review.
-
Targeting dysregulated lipid metabolism in the tumor microenvironment.Arch Pharm Res. 2023 Dec;46(11-12):855-881. doi: 10.1007/s12272-023-01473-y. Epub 2023 Dec 7. Arch Pharm Res. 2023. PMID: 38060103 Free PMC article. Review.
-
Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications.Biochem Pharmacol. 2023 Dec;218:115907. doi: 10.1016/j.bcp.2023.115907. Epub 2023 Nov 4. Biochem Pharmacol. 2023. PMID: 37931664 Review.
-
The updated landscape of tumor microenvironment and drug repurposing.Signal Transduct Target Ther. 2020 Aug 25;5(1):166. doi: 10.1038/s41392-020-00280-x. Signal Transduct Target Ther. 2020. PMID: 32843638 Free PMC article. Review.
-
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.J Immunother Cancer. 2022 Jan;10(1):e003717. doi: 10.1136/jitc-2021-003717. J Immunother Cancer. 2022. PMID: 35039461 Free PMC article.
Cited by
-
Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer.Nanomedicine (Lond). 2024;19(24):1977-1993. doi: 10.1080/17435889.2024.2382076. Epub 2024 Sep 3. Nanomedicine (Lond). 2024. PMID: 39225145
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
